PharmaSource: The External Manufacturing Community Your Biopharma Outsourcing Intelligence Hub Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter LATEST NEWS Leucid Bio: How Biology-First Thinking Should Drive Your CDMO Strategy Leucid Bio: How Biology-First Thinking Should Drive Your CDMO Strategy PharmaBlock Commissions First Peptide Pilot-Scale GMP Plant in Zhejiang WuXi Biologics Completes Topping Out of Singapore Drug Product Facility Sygnature Discovery and DaltonTx Collaborate to Advance AI-Enabled Decision-Making Across CRO Drug Discovery Programs Made Scientific Partners With Pluristyx to Expand iPSC Cell Therapy Manufacturing Services Lonza and Stipple Bio Sign Multi-Target ADC Licensing Agreement SCHOTT Pharma Invests Over $60M in U.S. Glass Vial Manufacturing Expansion Congress Proposes Federal Oversight for US-China Drug Licensing Deals Aurobindo Pharma Opens TheraNym Biologics CMO Facility in Telangana SK bioscience Secures First UNICEF Vaccine Procurement Contract Dark Horse Consulting Group and Altruist Biologics Sign MOU to Advance Biologics Development PharmaBlock Commissions First Peptide Pilot-Scale GMP Plant in Zhejiang WuXi Biologics Completes Topping Out of Singapore Drug Product Facility Sygnature Discovery and DaltonTx Collaborate to Advance AI-Enabled Decision-Making Across CRO Drug Discovery Programs PODCASTS From Crisis to Capability: What Will It Actually Take to Build a Resilient Global Vaccine Supply Chain? How Lonza Is Outgrowing the CDMO Market with Bioconjugation, AI, and Regionalization SPOTLIGHT Why Compliance-Driven CDMOs Win Sponsor Contracts RESOURCES CDMO Contract Negotiations Timelines Explained Target Product Profile (TPP) Explained Why Compliance-Driven CDMOs Win Sponsor Contracts UPCOMING EVENTS CDMO Live Europe 2027 CDMO Live Americas 2026 External Manufacturing Leaders Basel 2026
Sygnature Discovery and DaltonTx Collaborate to Advance AI-Enabled Decision-Making Across CRO Drug Discovery Programs
Sygnature Discovery and DaltonTx Collaborate to Advance AI-Enabled Decision-Making Across CRO Drug Discovery Programs
From Crisis to Capability: What Will It Actually Take to Build a Resilient Global Vaccine Supply Chain?